The beneficial effects of GIP on neurodegenerative diseases are well documented.57 Pharmacological concentrations of GIP agonists are more likely to provide protective effects against atherosclerosis in both patients with diabetic and non-diabetic conditions. This evidence concerns the gene GIP and atherosclerosis.